Beiersdorf Aktiengesellschaft (ETR:BEI)
| Market Cap | 15.41B -41.5% |
| Revenue (ttm) | 9.85B +0.0% |
| Net Income | 939.00M +3.0% |
| EPS | 4.25 +4.8% |
| Shares Out | 218.52M |
| PE Ratio | 16.60 |
| Forward PE | 16.17 |
| Dividend | 1.00 (1.42%) |
| Ex-Dividend Date | Apr 24, 2026 |
| Volume | 56,642 |
| Open | 71.02 |
| Previous Close | 70.34 |
| Day's Range | 70.94 - 71.80 |
| 52-Week Range | 67.08 - 114.35 |
| Beta | 0.48 |
| Analysts | Hold |
| Price Target | 88.05 (+23.77%) |
| Earnings Date | Aug 5, 2026 |
About ETR:BEI
Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia. The company operates through two segments: Consumer Business and Tesa Business. The Consumer Business Segment offers skin and body care products. The Tesa Business segment provides adhesive tapes and self-adhesive solutions for industries, craft businesses, and consumers. This segment also offers its system solutions to the automotive, consumer electronics, printing and packaging, ... [Read more]
Financial Performance
In 2025, ETR:BEI's revenue was 9.85 billion, an increase of 0.02% compared to the previous year's 9.85 billion. Earnings were 939.00 million, an increase of 2.96%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for BEI stock is "Hold." The 12-month stock price target is €88.05, which is an increase of 23.77% from the latest price.
News
Beiersdorf Aktiengesellschaft Transcript: AGM 2026
The AGM highlighted solid financial results amid a challenging market, with strategic focus on NIVEA's repositioning, innovation, and expansion in key markets. Shareholders approved all proposals, including a EUR 1 dividend and share buyback, while management addressed concerns on growth, acquisitions, and remuneration.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2026
Q1 2026 saw a 4.6% organic net sales decline, with Derma delivering strong growth and Nivea and La Prairie facing headwinds. Early signs of improved sell-out and ongoing strategic rebalancing support a cautiously optimistic outlook for the year.
Beiersdorf Aktiengesellschaft Earnings release: Q1 2026
Beiersdorf Aktiengesellschaft released its Q1 2026 earnings on April 21, 2026, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q1 2026
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 21, 2026.
Is Beiersdorf stock a buy after 44% crash? UBS upgrade offers key signals
Beiersdorf stock's long slump has finally been enough to make one major broker step back from its bearish stance. UBS upgraded the German skincare and consumer-goods group to “neutral” from “sell” on ...
Beiersdorf Shares Fall on Sluggish 2026 Outlook
The cosmetics company expects slow sales this year, particularly in its consumer business segment.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2025
Despite a challenging year marked by market slowdowns and cost pressures, the group delivered modest sales and profit growth, driven by strong Derma performance and innovation. Strategic repositioning of NIVEA and continued investment in R&D and shareholder returns are key priorities.
Beiersdorf Aktiengesellschaft Annual report: Q4 2025
Beiersdorf Aktiengesellschaft has published its Q4 2025 annual report on March 3, 2026.
Beiersdorf Aktiengesellschaft Earnings release: Q4 2025
Beiersdorf Aktiengesellschaft released its Q4 2025 earnings on March 3, 2026, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q4 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 3, 2026.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q3 2025
Group organic sales grew 1.7% in Q3, led by double-digit derma growth, while NIVEA faced mass market headwinds but saw strong September momentum from new launches. Full-year guidance was adjusted to 2.5% organic growth, with EBIT margin improvement expected.
Beiersdorf Aktiengesellschaft Earnings release: Q3 2025
Beiersdorf Aktiengesellschaft released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q3 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q2 2025
Group organic sales grew 2.1% in H1 2025, with strong Derma and Healthcare segments offsetting NIVEA's softness. Major innovation launches, especially EPICELLINE, are set to drive a stronger H2, though full-year Consumer growth guidance was lowered to 3%-4%.
Beiersdorf Aktiengesellschaft Quarterly report: Q2 2025
Beiersdorf Aktiengesellschaft has published its Q2 2025 quarterly earnings report on August 6, 2025.
Beiersdorf Aktiengesellschaft Slides: Q2 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 6, 2025.
Nivea-maker Beiersdorf's shares fall on lower sales forecast
Nivea-maker Beiersdorf's shares fell 10% on Wednesday after the company lowered its 2025 sales growth forecast late on Tuesday and warned of difficult market conditions.
Switzerland investigates Beiersdorf in dispute over Nivea pricing
The Swiss competition authority said on Tuesday it has opened an investigation into Beiersdorf over whether the German consumer goods group has relative market power over Swiss retailer Migros in a di...
Beiersdorf Sticks to Outlook After Solid Sales Growth
The personal-care products maker reported organic sales growth of 3.6% and backed its expectations for 2025.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q1 2025
Group organic sales grew 3.6% in Q1, led by strong Derma and Tesa performance, while China repositioning and travel retail weighed on results. Guidance for 4%-6% organic growth and higher EBIT margin is maintained, with improvement expected in H2 as innovation launches accelerate.
Beiersdorf Aktiengesellschaft Earnings release: Q1 2025
Beiersdorf Aktiengesellschaft released its Q1 2025 earnings on April 15, 2025, summarizing the period's financial results.
Beiersdorf Aktiengesellschaft Slides: Q1 2025
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on April 15, 2025.
Beiersdorf Aktiengesellschaft Earnings Call Transcript: Q4 2024
Record sales and profit growth in 2024, with strong performance in Consumer and Derma segments, margin expansion, and continued innovation. 2025 guidance anticipates 4%-6% organic growth, margin improvement, and ongoing investment in sustainability and digital.
Beiersdorf Aktiengesellschaft Annual report: Q4 2024
Beiersdorf Aktiengesellschaft has published its Q4 2024 annual report on February 27, 2025.
Beiersdorf Aktiengesellschaft Slides: Q4 2024
Beiersdorf Aktiengesellschaft has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on February 27, 2025.